The Fleming Fund

The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.

We support low- and middle-income countries to generate, share and use data to improve antimicrobial use and encourage investment in AMR.

Since 1999, ongoing national surveillance in Nepal shows antimicrobial resistance (AMR) is rising. However, data analysis on its drivers,…

Last week, Fleming Fund regional grantee the African Society of Laboratory Medicine (ASLM) held its sixth biennial conference, returning to…

A plaque on the side of the Saint Mary’s Hospital in Paddington, London, UK, commemorates the discovery of penicillin, the fir…

To mark One Health Day, we revisit the holistic concept spanning human, animal, and environmental health, which is one of the Fleming…


Up to £210 million of funding to partner with countries across Asia and Africa to tackle antimicrobial resistance and reduce the threa…

New country reports provide detailed accounts of drug resistance surveillance across the African continent to reduce the burden of AMR.

With global Sustainable Development Goals (SDGs) threatened by antimicrobial resistance (AMR), how can social science play a critical role…

There is a growing recognition that both sex (the physical dimension) and gender (the psychosocial dimension) – and the interaction betwe…


22
Active Country Grants
155
Countries have supplied data on use of antimicrobial medicines in animals to WOAH database
170
National Action Plans developed with Fleming Fund support
11
Active Regional Grants